Magnesium disorders from GI loss, diuretics, alcoholism (low), or renal failure and iatrogenic infusion (high).
Also known as: hypomagnesemia, hypermagnesemia, magnesium deficiency, low magnesium, high magnesium
Overview
Hypomagnesemia is serum magnesium <1.7 mg/dL (severe <1.0 mg/dL). Hypermagnesemia is >2.6 mg/dL (severe >4.0 mg/dL). Magnesium is the second most abundant intracellular cation. Homeostasis depends on intestinal absorption (~30-40% of intake) and renal handling: 70% reabsorbed in the thick ascending limb via paracellular transport (claudin-16/19) and 10% in the distal convoluted tubule (TRPM6).
Epidemiology
Hypomagnesemia is common: present in up to 12% of hospitalized patients and 60% of ICU patients. Hypermagnesemia is rare outside of obstetric magnesium therapy (preeclampsia/eclampsia), renal failure with magnesium-containing laxatives/antacids, or massive overdose.
🔒 Free preview limit reached
Keep reading — start your free trial
You've read your 2 free diagnosis previews. Create your free account to unlock the full Hypomagnesemia and Hypermagnesemia outline — plus all 514 diagnoses, 3,500+ board-style questions, flashcards, and an AI tutor. Your 7-day free trial includes everything, and there's no credit card required.
Hypomagnesemia: alcoholism, chronic diarrhea, malabsorption (celiac, IBD, short bowel, bariatric surgery), proton pump inhibitors (long-term), loop and thiazide diuretics, amphotericin B, aminoglycosides, pentamidine, cisplatin, calcineurin inhibitors (tacrolimus, cyclosporine), cetuximab/panitumumab (EGFR inhibitors), Gitelman and Bartter syndromes, type 2 diabetes
Hypermagnesemia: CKD/ESKD, magnesium-containing antacids (Maalox, milk of magnesia) and laxatives (especially in CKD), obstetric magnesium sulfate therapy, tumor lysis syndrome, lithium toxicity, hypothyroidism, Addison disease
Pathophysiology
Hypomagnesemia: from decreased intake (alcoholism, parenteral nutrition without Mg), decreased absorption (PPIs reduce TRPM6 expression and intestinal Mg uptake), or increased loss — renal (diuretics, calcineurin inhibitors, hereditary tubulopathies) or GI (diarrhea, vomiting). Magnesium is a cofactor for parathyroid hormone secretion and action — severe hypomagnesemia → functional hypoparathyroidism and refractory hypocalcemia. Hypermagnesemia: almost always from impaired renal excretion combined with an exogenous load (laxative, antacid, infusion). Suppresses neuromuscular transmission, causing weakness and bradyarrhythmias.
Clinical presentation
Symptoms
Hypomagnesemia: tremor, hyperreflexia, muscle cramps, paresthesias, tetany; seizures and ventricular arrhythmias (torsades de pointes) when severe; nausea, weakness, personality changes
Hypermagnesemia: nausea, flushing, headache, lethargy → loss of deep tendon reflexes (~5-7 mg/dL) → respiratory depression (>10) → bradyarrhythmias and cardiac arrest (>12 mg/dL)
Signs / physical exam
Hypomagnesemia: Trousseau and Chvostek signs (from coexisting hypocalcemia), hyperactive reflexes, fasciculations, prolonged QT and U waves on ECG, torsades
Hypermagnesemia: hyporeflexia (early, sensitive), bradycardia, hypotension, prolonged PR and QRS
Classic findings
Refractory hypokalemia and hypocalcemia in a patient with diuretic, alcohol, or PPI use — always replace magnesium first. Loss of patellar reflex in a preeclamptic patient on magnesium sulfate — first sign of toxicity.
Differential diagnosis
Hypocalcemia (other causes) — Hypoparathyroidism, vitamin D deficiency, CKD; check Mg in any refractory hypocalcemia
Hypokalemia (other causes) — Often coexists with hypomagnesemia; cannot fully correct K until Mg replaced (Mg-dependent ROMK channel)
Magnesium disorder severity and management thresholds.
Treatment
First-line
Hypomagnesemia, mild-moderate, asymptomatic: oral magnesium oxide, magnesium chloride, or magnesium lactate 240-1000 mg elemental Mg/day in divided doses (diarrhea is common dose-limiting effect; sustained-release preparations better tolerated)
Hypomagnesemia, severe or symptomatic (arrhythmia, seizure, tetany): IV magnesium sulfate 1-2 g over 15-60 min (faster if life-threatening), then 4-8 g over 24 hours; for torsades, 2 g IV push
Replace magnesium BEFORE potassium when both are low (potassium repletion is futile in untreated hypomagnesemia)
Identify and treat underlying cause — discontinue offending drug, address malabsorption
Hypermagnesemia, mild-moderate, asymptomatic: discontinue magnesium sources, supportive observation; renal excretion clears Mg if kidney function adequate
Hypermagnesemia, symptomatic or severe: IV calcium gluconate or calcium chloride for cardioprotection (calcium antagonizes Mg at NMJ); IV fluids and loop diuretic (furosemide) to enhance renal excretion; hemodialysis for severe toxicity or anuric patients
Watch for refeeding syndrome with concurrent phosphate, potassium derangement
PPI-associated hypomagnesemia
Trial of stopping PPI or switching to H2 blocker
Oral magnesium replacement; severe cases may need IV courses
Consider amiloride (potassium-sparing diuretic) to increase distal Mg reabsorption
Magnesium sulfate toxicity in obstetrics
Discontinue infusion
IV calcium gluconate 1 g over 5-10 min
Supportive ventilation if respiratory depression
Continuous cardiac monitoring; monitor DTRs as bedside marker
Gitelman / Bartter syndromes
Long-term oral KCl and Mg replacement
Amiloride or spironolactone for potassium and magnesium retention
NSAIDs for Bartter (reduce prostaglandin-driven losses) — cautious use
Second-line / adjunct
Amiloride for chronic refractory renal magnesium wasting
Inulin or pectin-rich diet to improve magnesium absorption (anecdotal)
Burosumab is NOT used for Mg disorders — distinguish from phosphate
Complications
Hypomagnesemia: torsades de pointes and other ventricular arrhythmias, sudden cardiac death, refractory hypokalemia and hypocalcemia, seizures, osteoporosis (long-term), worse outcomes in heart failure and ICU populations
Hypermagnesemia: respiratory failure, cardiac arrest, profound hypotension, ileus, urinary retention; fetal hypotonia and Apgar reduction in neonates of preeclamptic mothers
PANCE pearls
Always check and replete magnesium in refractory hypokalemia or hypocalcemia — potassium cannot be retained without adequate magnesium.
Loss of patellar reflex is the earliest bedside sign of magnesium sulfate toxicity in preeclamptic patients — check reflexes hourly during infusion.
Long-term PPI use is a frequently overlooked cause of hypomagnesemia; FDA boxed warning since 2011.
IV magnesium 2 g push is first-line therapy for torsades de pointes regardless of baseline magnesium level.
FEMg >2% in a hypomagnesemic patient indicates inappropriate renal wasting and points toward diuretics, calcineurin inhibitors, EGFR inhibitors, or a hereditary tubulopathy.
References
FDA 2011 — FDA Drug Safety Communication: Low magnesium levels can be associated with long-term use of proton pump inhibitor drugs (PPIs) (2011)
ACOG 2020 — ACOG Practice Bulletin No. 222: Gestational Hypertension and Preeclampsia (Obstet Gynecol 2020;135:e237-e260)
Educational use only. This outline is a study aid for PA students and is not medical advice or a substitute for clinical judgment. FirstPassPA is an independent study tool and is not affiliated with, endorsed by, or sponsored by NCCPA. PANCE® and PANRE® are registered trademarks of the National Commission on Certification of Physician Assistants.